July 14, 2022 Comments Off on New patent for Albireo drug BYLVAY Posted in: Patent Added Annual Drug Patent Expirations for BYLVAY Bylvay is a drug marketed by Albireo and is included in one NDA. There are seven patents protecting this drug. This drug has one…
The post New patent for Albireo drug BYLVAY appeared first on DrugPatentWatch – …
July 14, 2022 Comments Off on New patent for Teva Pharm drug AIRDUO RESPICLICK Posted in: Patent Added Annual Drug Patent Expirations for AIRDUO+RESPICLICK Airduo Respiclick is a drug marketed by Teva Pharm and is included in one NDA. It is available from four suppliers. There are sixteen…
The post New patent for Teva Pharm drug AIRDUO RESPICLICK appear…
